Roberta J. Secrest

3.3k citations

27 papers · 2.5k indexed · 2 hit papers · h-index 16

Impact in

Dermatology top 0.5%
- Dermatology and Skin Diseases
Immunology top 2%
- Psoriasis: Treatment and Pathogenesis

Papers in

Urology 5
- Urinary Bladder and Prostate Research 5
Pharmacology 7
- Inflammatory mediators and NSAID effects 4

Co-authors: Kim Papp J. Erickson Kristian Reich Olawale Osuntokun Brian J. Nickoloff Susan Ball Daniel Braun Gregory S. Cameron
Journals: Journal of Pharmacology and Experimental Therapeutics (4 papers)Journal of Clinical Oncology (4 papers)Circulation Research (2 papers)The Journal of Sexual Medicine (2 papers)European Urology (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Roberta J. Secrest

27 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis 2016 · 650 citations

Peers

Countries citing papers authored by Roberta J. Secrest

Since Specialization

Citations

This map shows the geographic impact of Roberta J. Secrest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta J. Secrest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta J. Secrest more than expected).

Fields of papers citing papers by Roberta J. Secrest

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta J. Secrest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta J. Secrest. The network helps show where Roberta J. Secrest may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Roberta J. Secrest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberta J. Secrest Line = papers co-authored together Roberta J. Secrest links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis Journal of Patient-Reported Outcomes ·Louise Newton, Jason A. Randall, Theresa Hunter, 奎申小菅, Tara Symonds, Roberta J. Secrest, Wendy Komocsar, Sarah Curtis, Linda Abetz‐Webb, Michael D. Kappelman, April N. Naegeli	2019	28
2	Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis New England Journal of Medicine ·Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi Hit paper breakdown →	2016	650
3	Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials The Lancet ·C.E.M. Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, C. Paul, Alan Menter, Gregory S. Cameron, J. Erickson, Lu Zhang, Roberta J. Secrest, Susan Ball, Daniel Braun, Olawale Osuntokun, Michael Heffernan, Brian J. Nickoloff, Kim Papp Hit paper breakdown →	2015	658
4	Effects of Tadalafil on Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia and on Erectile Dysfunction in Sexually Active Men with Both Conditions: Analyses of Pooled Data from Four Randomized, Placebo-Controlled Tadalafil Clinical Studies The Journal of Sexual Medicine ·Hartmut Porst, Claus G. Roehrborn, Roberta J. Secrest, Anne Esler, Lars Viktrup	2013	44
5	Tadalafil Administered Once Daily for Treatment of Lower Urinary Tract Symptoms in Korean men with Benign Prostatic Hyperplasia: Results from a Placebo‐Controlled Pilot Study Using Tamsulosin as an Active Control LUTS Lower Urinary Tract Symptoms ·Sae Chul Kim, Jong Kwan Park, Sae Woong Kim, Sung Won Lee, Tai Young Ahn, Je Jong Kim, Jae‐Seung Paick, Nam Cheol Park, Kwangsung Park, Kweon Sik Min, Stephen R. Kraus, Roberta J. Secrest, Albert Elion‐Mboussa, Lars Viktrup	2011	42
6	Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial European Urology ·Hartmut Porst, Edward D. Kim, Adolfo Casabé, Vincenzo Mirone, Roberta J. Secrest, Lei Xu, David P. Sundin, Lars Viktrup	2011	137
7	Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo-Controlled, Double-Blind Study The Journal of Sexual Medicine ·R. Blair Egerdie, Stephen M. Auerbach, Claus G. Roehrborn, Pierre Costa, Fabio Daniel Barbosa, Anne Esler, David G. Wong, Roberta J. Secrest	2011	111
8	Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene JNCI Journal of the National Cancer Institute ·Silvana Martino, Jane A. Cauley, Elizabeth Barrett‐Connor, Trevor J. Powles, John L. Mershon, Damon Disch, Roberta J. Secrest, Steven R. Cummings, (unknown)	2004	487
9	The Role of Selective Estrogen Receptor Modulators in the Prevention of Breast Cancer: Comparison of the Clinical Trials The Oncologist ·Silvana Martino, Joseph P. Costantino, Michelle McNabb, John L. Mershon, Katherine Bryant, Trevor J. Powles, Roberta J. Secrest	2004	31
10	Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial Journal of Clinical Oncology ·Silvana Martino, Jane A. Cauley, E. Barrett-Connor, T.J. Powles, John L. Mershon, Damon Disch, Roberta J. Secrest, Steven R. Cummings	2004	3
11	Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial Journal of Clinical Oncology ·Silvana Martino, Jane A. Cauley, Elizabeth Barrett‐Connor, T.J. Powles, John L. Mershon, Damon Disch, Roberta J. Secrest, Steven R. Cummings	2004	8
12	Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women American Journal of Obstetrics and Gynecology ·Valerie P. Jackson, Achal Pandya, Roberta J. Secrest, Michelle McNabb, Sebastián Carranza‐Lira, Daniel Gregg, César Eduardo Fernandes, Josefina Romaguera	2003	29
13	Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene Reproduction Fertility and Development ·D. Thiébaud, Roberta J. Secrest	2001	15
14	The Synthesis and Biological activity of a Highly Selective Adenosine A_2a. Receptor Agonist Nucleosides and Nucleotides ·David R. Borcherding, Marcus Vinícius de Sousa Lopes, Philip M. Weintraub, Mark W. Dudley, Roberta J. Secrest, Philip R. Kastner, Norton P. Peet, Schmickal Th.	1999	2
15	Hypotensive Properties of the Protein Kinase Inhibitor, Staurosporine, in Normotensive and Spontaneously Hypertensive Rats Clinical and Experimental Hypertension Part A Theory and Practice ·Roberta J. Secrest, Amelia Muñoz-Lerma, Rosanne Bonjouklian, Shinji Sameshima, Kenneth Firman, John Turk, Marlene L. Cohen	1991	6
16	Role of endothelium in responses of isolated hepatic vessels to vasoactive agents. Journal of Pharmacology and Experimental Therapeutics ·Shobha Joshi, Andrew J. Lonigro, Roberta J. Secrest, B. M. Chapnick	1991	6
17	Protein kinase C translocation in rat stomach fundus: effects of serotonin, carbamylcholine and phorbol dibutyrate. Journal of Pharmacology and Experimental Therapeutics ·Roberta J. Secrest, Virginia L. Lucaites, L G Mendelsohn, Marlene L. Cohen	1990	15
18	Endothelin: Differential effects in vascular and nonvascular smooth muscle Life Sciences ·Roberta J. Secrest, Marlene L. Cohen	1989	30
19	Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus. Journal of Pharmacology and Experimental Therapeutics ·Roberta J. Secrest, D D Schoepp, Marlene L. Cohen	1989	18
20	Relationship between LTD4-induced endothelium-dependent vasomotor relaxation and cGMP. Journal of Pharmacology and Experimental Therapeutics ·Roberta J. Secrest, Kai Jian Yang, B. M. Chapnick	1988	8

About Roberta J. Secrest

Roberta J. Secrest is a scholar working on Urology, Pharmacology, Biochemistry, Genetics and Pharmacology, having authored 27 papers that have together received 2.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (9 papers), Cancer Risks and Factors (7 papers), Nitric Oxide and Endothelin Effects (5 papers), Urinary Bladder and Prostate Research (5 papers), Sexual function and dysfunction studies (4 papers), Hormonal and reproductive studies (4 papers), Breast Cancer Treatment Studies (4 papers) and Inflammatory mediators and NSAID effects (4 papers). The work is most often cited by research in Dermatology (734 citations), Immunology (1.2k citations), Urology (303 citations), Orthopedics and Sports Medicine (259 citations) and Rheumatology (299 citations). Roberta J. Secrest has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Kim Papp, J. Erickson, Kristian Reich, Olawale Osuntokun, Brian J. Nickoloff, Susan Ball, Daniel Braun, Gregory S. Cameron, John L. Mershon and Silvana Martino. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Clinical Oncology, Circulation Research, The Journal of Sexual Medicine and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact